Kobo Biotech share news, announcements and annual reports

BSE: 531541Chemicals & PetrochemicalsSmall Cap

KOBO BIOTECH LIMITED · Face value ₹10 · Listed Mar 2000

₹3.80₹0.07 (1.81%)

Share price at the BSE close on 30 Oct 2026. Previous close ₹3.87.

30 Oct: open ₹3.80, high ₹3.80, low ₹3.80

52-week range of traded prices to 30 Oct 2026

₹1.99Low, 11 Dec 2025₹9.99High, 20 Jul 2026

Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.

Market cap: ₹9.05 Cr4,799th largest listed
P/E: No recent results
P/B: No recent results
Dividend yield: Nonein the last 12 months
Volume, BSE: 5,152

Kobo Biotech share news and announcements

420 announcements, routine notices left out, newest first. Page 6 of 9.

Jan 2018
- 21 Jan
  Statement of investor grievance report for the quarter ended 31 December 2017
Dec 2017
- 14 Dec · Results
  This is to inform the exchange that the Board of Directors of the Company at its meeting held today i.e. 14 December 2017 inter alia, has approved unaudited Financial Results for the quarter ....
Oct 2017
- 26 Oct · Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements), 2015 For Half Year Ended 30Th September 2017
  Please find attached herewith a copy of compliance certificate issued by XL Softech Systems Ltd., Share Transfer Agent. The same may please be taken on record and suitably disseminated ....
- 18 Oct · Shareholding for the Period Ended September 30, 2017
  Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....
- 18 Oct
  Statement of Investor Complaints for Quarter ended 30-09-2017
- 18 Oct
  Compliance Certificate under regulation 40(9) for half year ended 30-09-2017
- 11 Oct · Legal
  Clarification is enclosed.
- 11 Oct · Legal
  Exchange has sought clarification from Avon Lifesciences Ltd on October 11, 2017, with reference to increase in Price. The reply is awaited.
Sep 2017
- 14 Sep · Results
  This is to inform the exchange that the Board of Directors of the Company at its meeting held today i.e. 14 September 2017 inter alia, has approved unaudited Financial Results for the quarter ....
- 7 Sep · Board Meeting On 14 September 2017
  This is to inform the exchangethat a meeting of the Board of Directors of the Company is scheduled to be held on 14th September 2017, inter alia, to consider and approve the Unaudited financial ....
Jul 2017
- 21 Jul · Investor Grievance Report For The Quarter Ended 30Th June 2017
  Enclosed please find the Investor Grievance Report of the Company for the Quarter ....
- 21 Jul · Shareholding for the Period Ended June 30, 2017
  Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....
May 2017
- 30 May · Board meeting
  This is to inform you that at the Meeting of the Board of Directors of Avon Lifesciences Limited held on Tuesday, 30th day of May, 2017, at the corporate office of the Company, the following ....
Apr 2017
- 21 Apr · Shareholding for the Period Ended March 31, 2017
  Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....
- 12 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements), 2015
  With regards to the captioned matter, Please find attached herewith a copy of compliance certificate issued by XL Softech Systems Ltd., Share Transfer Agent. The same may please be taken ....
- 12 Apr · Compliance Certificate Pursuant To Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations) For The Period October 1, 2016 To March 31, 2017
  With regards to the captioned matter, Please find attached herewith a copy of compliance certificate issued by Uma Ramakanth, Practicing Company Secretary for the period October 1, 2016 ....
- 12 Apr · Statement Of Investor Complaints For The Quarter Ended On 31.03.2017
  Please find below the Statement of Investor Complaints for the quarter ended 31st March, 2017. S.No Particulars Details (In Numbers) 1. Number of Investor complaints pending at the beginning of the quarter NIL 2 Number of Investor Complaints received during the quarter NIL 3 Number of Investor Complaints disposed of during the quarter NIL 4 Number of Investor Complaints remaining
Feb 2017
- 14 Feb · Board meeting
  Company had issued 1,05,00,000 Share warrants @ Rs. 26 per share warrant, which were convertible into equivalent number of Equity Shares ....
- 14 Feb · Results
  1. Standalone Financial Results for the period ended December 31, 2016 2. Standalone Limited Review for the period ended December 31, 2016
Jan 2017
- 13 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) ....
- 12 Jan · Shareholding for the Period Ended December 31, 2016
  Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....
Dec 2016
- 30 Dec · Updates
  Company is incapacitated to hold the Annual General Meeting (AGM) within the extended period of December 31, 2016 as was permitted by the ....
Nov 2016
- 11 Nov · Results
  1. Standalone Financial Results for the period ended September 30, 2016 2. Standalone Limited Review for the period ended September ....
- 11 Nov · Shareholding for the Period Ended September 30, 2016
  Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....
- 10 Nov · Updates
  Company had received a Suspension Notice on November 07, 2016 stating that the scrip of the Company would be suspended w.e.f November 29, ....
- 10 Nov · Shareholding for the Period Ended June 30, 2016
  Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click ....
Oct 2016
- 29 Oct · Results
  1. Standalone Financial Results for the period ended June 30, 2016 2. Standalone Limited Review for the period ended June 30, 2016
- 28 Oct · Change in Communication Address
  Change in Communication address & email
- 28 Oct · Board meeting
  Meeting of the Board of Directors of the Company is scheduled to be held on October 29, 2016, inter alia, to consider the unaudited financial ....
- 24 Oct · Results
  1. Standalone Financial Results for the period ended March 31, 2016 2. Standalone Auditors Report for the period ended March 31, 2016 ....
- 24 Oct · Board meeting
  Board of Directors of the Company at its meeting held on October 24, 2016, inter alia, has transacted the following agenda: - An update ....
- 22 Oct · Board Meetign on Oct 24, 2016
  Meeting of the Board of Directors of the Company will be held on October 24, 2016, for the following: 1. To take on record the Audited ....
May 2016
- 30 May · Results
  Extension of time for filing Financial Results.
Apr 2016
- 28 Apr · Update- Drug Seizure case
  Company's Whole-time Director, Mr. Manoj Jain, has been remanded to Police Custody in connection with a Drug Seizure case, which the Company ....
- 25 Apr · Conversion of Warrants into Equity
  As per the terms of 1,05,00,000 (One Crore Five Lacs) Warrants issued by the Company on August 12, 2015 on preferential basis, the Allotment ....
- 21 Apr · Shareholding for the Period Ended March 31, 2016
  Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click ....
- 21 Apr · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) ....
- 18 Apr · Legal
  This refers to the various news articles in various media about a Drug Seizure involving our company. The company is cooperating with ....
- 11 Apr · Conversion of Warrants in to Equity
  As per the terms of 1,05,00,000 (One Crore Five Lacs) Warrants issued by the Company on August 12, 2015 on preferential basis, the Allotment ....
Feb 2016
- 12 Feb · Results
  1. Standalone Financial Results for the period ended December 31, 2015 2. Standalone Limited Review for the period ended December 31, 2015
Jan 2016
- 29 Jan · Shareholding for the Period Ended December 31, 2015
  Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click ....
- 22 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) ....
Dec 2015
- 9 Dec · Conversion of Warrants in to Equity
  As per the terms of 1,05,00,000 (One Crore Five Lacs) Warrants, issued by the Company on August 12, 2015 ott preferential basis, the Allotment ....
Nov 2015
- 27 Nov · Conversion of Warrants into Equity
  As per the terms of 1,05,00,000 (One Crore Five Lacs) Warrants issued by the Company on August 12, 2015 on preferential basis, the Allotment ....
- 6 Nov · Conversion of Warrants in to Equity
  As per the terms of 1,05,00,000 (One Crore Five Lacs) Warrants issued by the Company on August 12, 2015 on preferential basis, the Allotment ....
- 6 Nov · Results
  Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30,2015.
- 4 Nov · Conversion of Warrants in to Equity
  As per the terms of 1,05,00,000 (One Crore Five Lacs) Warrants issued by the Company on August 12, 2015 on preferential basis, the Allotment ....
- 2 Nov · Outcome of Allotment Committee Meeting
  As per the terms of 1,05,00,000 (One Crore Five Lacs) Warrants issued by the Company on August 12, 2015 on preferential basis, the Allotment ....
Oct 2015
- 26 Oct · Outcome of Allotment Committee Meeting
  Outcome of Allotment Committee Meeting held on October 26, 2015.
- 21 Oct · Conversion of Warrants in to Equity
  As per the terms of 1,05,00.000 (One Crore Five Lacs) Warrants issued by the Company on August 12, 2015 on preferential basis, the Allotment ....

Kobo Biotech share news and announcements

Jan 2018

Dec 2017

Oct 2017

Sep 2017

Jul 2017

May 2017

Apr 2017

Feb 2017

Jan 2017

Dec 2016

Nov 2016

Oct 2016

May 2016

Apr 2016

Feb 2016

Jan 2016

Dec 2015

Nov 2015

Oct 2015